MoneyWorks4Me

SMS Pharmaceuticals informs about press release

29 Aug 2026 Evaluate
SMS Pharmaceuticals has informed that it enclosed copies of the newspaper advertisement published on 29th August, 2026, informing the shareholders about the 38th Annual General Meeting of SMS Pharmaceuticals to be held on Tuesday, 29th September, 2026 at 10.30 am IST through Video Conference or Other Audio Visual Means, in compliance with the Circulars issued by the Ministry of Corporate Affairs (MCA) and Securities Exchange Board of India (SEBI). The advertisement has been published in the following newspapers: Financial Express (in English Language); Nava Telangana (in Telugu Language). The newspaper advertisements is also made available on the website of the Company www.smspharma.com at Investors section.

The above information is a part of company’s filings submitted to BSE.

SMS Pharmaceuticals Share Price

355.40 -7.35 (-2.03%)
28-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1920.10
Dr. Reddys Labs. 1177.80
Cipla 1418.00
Lupin 2175.00
Zydus Lifesciences 1187.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: